Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC Secretome in Moderate Rheumatoid Arthritis
NCT07715045Phase 2Completed
- Sponsor
- Universitas Sriwijaya
- Start
- Feb 2026
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord-derived mesenchymal stromal cell secretome in rheumatoid arthritis (RA), sponsored by Universitas Sriwijaya. Started Feb 2026; status: completed.
02
Drugs
umbilical cord-derived mesenchymal stromal cell secretome
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07715045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07715045.